  |
Overview
Novogen is building a major pharmaceutical opportunity based on an exciting and innovative concept -
- that a family of naturally-occurring plant compounds known as flavonoids are an important and primitive regulator of such basic functions of cells in Nature as how they survive and maintain normal vigor and then die at a predetermined time
- that such effects occur also in human cells
- that humans consume flavonoids in such substantial quantities that they undoubtedly make a major contribution to human health
- that the primary health benefit to humans is that by maintaining the normal vigor and fundamental behavior of cells, they help prevent the onset of degenerative disease.
Novogen has built on this discovery by selecting a sub-group of flavonoids - the isoflavonoids - and using these to create a range of products with specific benefits in various disease states.The technology platform is known as the Novogen Isoflavonoid Technology Platform.
|
|
|
